Family Nursing for Patients With Chronic Nonmalignant Pain

2019 ◽  
Author(s):  
Keyword(s):  
Family Nursing ◽  
Nonmalignant Pain ◽  
Chronic Nonmalignant Pain

Management of Chronic Nonmalignant Pain

1998 ◽  
Vol 11 (5) ◽  
pp. 374-381 ◽  
Author(s):  
James T. O'Donnell ◽  
Moriah B. Richie ◽  
Lori A. Nesbitt
Keyword(s):  
Chronic Pain ◽  
Clinical Research ◽  
Interpersonal Relationships ◽  
State Level ◽  
Social Consequences ◽  
High Quality ◽  
Level Of Functioning ◽  
Nonmalignant Pain ◽  
Chronic Nonmalignant Pain

Although advances in knowledge about the pathophysiology of pain have been impressive in recent years, high-quality clinical research in patients with chronic pain has not been abundant. Because chronic pain often leads to profound changes in psychologic state, level of functioning, and interpersonal relationships, treatment requires attention not only to the pathophysiologic cause of the pain (if one can be found) but also to the psychologic and social consequences (and antecedents).

scholarly journals Extended-Release, Once-Daily Morphine (Avinza) for the Treatment of Chronic Nonmalignant Pain: Effect on Pain, Depressive Symptoms, and Cognition

Pain Medicine ◽  
2008 ◽  
Vol 9 (8) ◽  
pp. 985-993 ◽  
Author(s):  
Sumeet S. Panjabi ◽  
Ravi S. Panjabi ◽  
Marvin D. Shepherd ◽  
Kenneth A. Lawson ◽  
Michael Johnsrud ◽  
...  
Keyword(s):  
Depressive Symptoms ◽  
Extended Release ◽  
Once Daily ◽  
Nonmalignant Pain ◽  
Chronic Nonmalignant Pain

Interferences With Urine Drug Screens

2010 ◽  
Vol 24 (1) ◽  
pp. 102-108 ◽  
Author(s):  
Charles Herring ◽  
Andrew J. Muzyk ◽  
Cynthia Johnston
Keyword(s):  
Screening Tests ◽  
Test Results ◽  
Appropriate Use ◽  
Additional Information ◽  
Concurrent Use ◽  
Nonmalignant Pain ◽  
Urine Drug ◽  
Drug Assays ◽  
Chronic Nonmalignant Pain ◽  
Urine Drug Screening

Qualitative urine drug assays are frequently used in conjunction with opioid contracts as a means of monitoring use of prescribed controlled substances as well as concurrent use of illicit substances in patients receiving opioids for chronic nonmalignant pain (CNMP) management. Appropriate use of these screening tests, in conjunction with opioid contracts, may provide the health care provider with additional information needed to safely prescribe opioids for selected individuals with CNMP. It is important for the practitioner caring for patients subject to random urine drug screening to understand interferences with the commonly used urine drug assays, as well as knowing options to confirm contested test results. We reviewed the literature on urine drug assay test interferences and present a summary of this information in this article.

Sign in / Sign up

Export Citation Format

Share Document